Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.58 |
| ▸ | CYP1A2 | P05177 | 3/20 | 0.58 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.58 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.58 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.58 |
| ▸ | HIF1A | Q16665 | 2/20 | 0.58 |
| ▸ | HPGD | P15428 | 1/20 | 0.58 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.58 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.58 |
| ▸ | L3MBTL1 | Q9Y468 | 3/20 | 0.50 |
| ▸ | CA1 | P00915 | 1/20 | 0.50 |
| ▸ | CA2 | P00918 | 1/20 | 0.50 |
| ▸ | MEN1 | O00255 | 3/20 | 0.48 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.48 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.48 |
| ▸ | RAB9A | P51151 | 5/20 | 0.48 |
| ▸ | NPC1 | O15118 | 4/20 | 0.48 |
| ▸ | MAPT | P10636 | 2/20 | 0.48 |
| ▸ | CYP2A6 | P11509 | 2/20 | 0.48 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL1873124 | 0.98 | ALDH1A1 (0.56) | ALDH1A1CYP1A2CYP3A4HSD17B10CYP2C19 | |
| SCHEMBL6759670 | 0.93 | ALDH1A1 (0.50) | ALDH1A1CYP1A2CYP3A4HSD17B10CYP2C19 | |
| Toluene SCHEMBL28366625 | 0.89 | ALDH1A1 (0.53) | ALDH1A1CYP1A2CYP3A4HSD17B10CYP2C19 | |
| SCHEMBL8156941 | 0.89 | EGFR (0.48) | ALDH1A1CYP1A2CYP3A4HSD17B10CYP2C19 | |
| SCHEMBL25973229 | 0.87 | EGFR (0.47) | ALDH1A1CYP1A2CYP3A4HSD17B10CYP2C19 | |
| SCHEMBL23192909 | 0.82 | ESR1 (0.55) | ALDH1A1CYP1A2CYP3A4HSD17B10CYP2C19 | |
| SCHEMBL16194105 | 0.82 | ALDH1A1 (0.54) | ALDH1A1CYP1A2CYP3A4HSD17B10CYP2C19 | |
| SCHEMBL13562995 | 0.82 | ALDH1A1 (0.48) | ALDH1A1CYP1A2CYP3A4HSD17B10CYP2C19 | |
| SCHEMBL16194322 | 0.81 | HPRT1 (0.56) | ALDH1A1CYP1A2HSD17B10HIF1AHPGD | |
| SCHEMBL27937772 | 0.81 | ESR1 (0.52) | ALDH1A1CYP3A4HSD17B10HPGDNPC1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 362 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-116903518-A | Synthesis method of N-methyl-4, 5-benzindole | 太原理工大学 | 2023-10-20 | — | — | CN | claimed |
| CN-111704591-B | Synthesis method of copper-catalyzed thionaphthothiazolone compound | 衡阳师范学院 | 2023-05-16 | — | — | CN | claimed |
| CN-109336887-B | Benzimidazole chiral heterocyclic compound and preparation method and application thereof | 中山大学 | 2021-12-17 | — | — | CN | claimed |
| US-11066749-B2 | Corrosion inhibition of HCL treatment fluids with environmentally compatible solvent | HALLIBURTON ENERGY SERVICES, INC. (US) | 2021-07-20 | — | — | US | claimed |
| CN-111704591-A | Synthesis method of copper-catalyzed thio-naphthothiazolone compound | 衡阳师范学院 | 2020-09-25 | — | — | CN | claimed |
| US-20200173034-A1 | Corrosion Inhibition of HCL Treatment Fluids with Environmentally Compatible Solvent | HALLIBURTON ENERGY SERVICES, INC. (US) | 2020-06-04 | — | — | US | claimed |
| US-10604850-B2 | Corrosion inhibition of HCL treatment fluids with environmentally compatible solvent | HALLIBURTON ENERGY SERVICES, INC. (US) | 2020-03-31 | — | — | US | claimed |
| CN-110669058-A | Tricyclic quinolone carboxylic acid and preparation method thereof | 江西农业大学 | 2020-01-10 | — | — | CN | claimed |
| US-20180127882-A1 | Corrosion Inhibition of HCL Treatment Fluids with Environmentally Compatible Solvent | HALLIBURTON ENERGY SERVICES, INC. (US) | 2018-05-10 | — | — | US | claimed |
| WO-2016190865-A1 | CORROSION INHIBITION OF HCL TREATMENT FLUIDS WITH ENVIRONMENTALLY COMPATIBLE SOLVENT | HALLIBURTON ENERGY SERVICES, INC. (US) | 2016-12-01 | — | — | WO | claimed |
| EP-2646600-A1 | CORROSION INHIBITOR COMPOSITIONS COMPRISING REACTION PRODUCTS OF ALDEHYDES AND AMIDES AND RELATED METHODS | Halliburton Energy Services, Inc. (US) | 2013-10-09 | — | — | EP | claimed |
| US-8361937-B2 | Corrosion inhibitor compositions comprising reaction products of aldehydes and amides and related methods | HALLIBURTON ENERGY SERVICES, INC. (US) | 2013-01-29 | — | — | US | claimed |
| WO-2012072986-A1 | CORROSION INHIBITOR COMPOSITIONS COMPRISING REACTION PRODUCTS OF ALDEHYDES AND AMIDES AND RELATED METHODS | HALLIBURTON ENERGY SERVICES, INC. (US) | 2012-06-07 | — | — | WO | claimed |
| US-20120142563-A1 | Corrosion Inhibitor Compositions Comprising Reaction Products of Aldehydes and Amides and Related Methods | HALLIBURTON ENERGY SERVICES, INC. (US) | 2012-06-07 | — | — | US | claimed |
| EP-0853618-B1 | SUBSTITUTED (SULFINIC ACID, SULFONIC ACID, SULFONYLAMINO OR SULFINYLAMINO) N- (AMINOIMINOMETHYL)PHENYLALKYL -AZAHETEROCYCLYLAMIDE COMPOUNDS | AVENTIS PHARMA INC (US) | 2011-08-17 | — | — | EP | claimed |
| US-6984673-B2 | Dental cement composition | KURARAY CO., LTD. (JP) | 2006-01-10 | — | — | US | claimed |
| CN-1553897-A | Dolastatin 10 derivatives | - | 2004-12-08 | — | — | CN | claimed |
| CN-1114669-C | Normal temp. solidified conveying band joint chloroprene rubber adhesive | HUANG SHIDE (CN) | 2003-07-16 | — | — | CN | claimed |
| CN-1272520-A | Normal temp. solidified conveying band joint chloroprene rubber adhesive | HUANG HONGXIA (CN) | 2000-11-08 | — | — | CN | claimed |
| US-20260112544-A1 | ELECTROLYTIC CAPACITOR | PANASONIC IP MAN CO LTD (JP) | 2026-04-23 | — | — | US | disclosed |
| US-12531188-B2 | Electrolytic capacitor | PANASONIC INTELLECTUAL PROPERTY MANAGEMENT CO., LTD. (JP) | 2026-01-20 | — | — | US | disclosed |
| US-20250361236-A9 | DIACYLGLYCEROL KINASE MODULATING COMPOUNDS | GILEAD SCIENCES INC (US) | 2025-11-27 | — | — | US | disclosed |
| CN-120058683-A | SLC6A19 inhibitor compound, pharmaceutical composition, preparation method and application thereof | 长春金赛药业有限责任公司 | 2025-05-30 | — | — | CN | disclosed |
| CN-116283683-B | Method for synthesizing diaryl thioether amine compound by photoinduction catalysis | 衡阳师范学院 | 2025-05-23 | — | — | CN | disclosed |
| WO-2025089384-A1 | PHOTOELECTRIC CONVERSION ELEMENT AND PHOTOELECTRIC CONVERSION DEVICE | キヤノン株式会社 | 2025-05-01 | — | — | WO | disclosed |
| WO-2025051157-A1 | PYRIDINE-2(1H)-KETONE PRMT5-MTA INHIBITOR, AND PHARMACEUTICAL COMPOSITION AND USE THEREOF | 赛诺哈勃药业（成都）有限公司 | 2025-03-13 | — | — | WO | disclosed |
| US-20240400568-A1 | DIACYLGLYCEROL KINASE MODULATING COMPOUNDS | GILEAD SCIENCES, INC. | 2024-12-05 | — | — | US | disclosed |
| WO-2024241889-A1 | CHARGE-TRANSPORTING VARNISH | 日産化学株式会社 | 2024-11-28 | — | — | WO | disclosed |
| EP-4445902-A2 | DIACYLGLYCEROL KINASE MODULATING COMPOUNDS | Carna Biosciences, Inc. (JP) | 2024-10-16 | — | — | EP | disclosed |
| EP-4081305-B1 | DIACYLGLYCEROL KINASE MODULATING COMPOUNDS | CARNA BIOSCIENCES INC (JP) | 2024-09-18 | — | — | EP | disclosed |
| US-12075637-B2 | Perovskite solar cell and fabrication method thereof | CONTEMPORARY AMPEREX TECHNOLOGY CO., LIMITED (CN) | 2024-08-27 | — | — | US | disclosed |
| US-12054490-B2 | Diacylglycerol kinase modulating compounds | GILEAD SCIENCES, INC. (US) | 2024-08-06 | — | — | US | disclosed |
| CN-118324767-A | Diacylglycerol kinase modulating compounds | 卡尔那生物科学株式会社 | 2024-07-12 | — | — | CN | disclosed |
| EP-4393923-A1 | PYRIDO RING COMPOUND, PREPARATION METHOD THEREFOR, INTERMEDIATE, COMPOSITION, AND APPLICATION | Yiyou Biotech (Shanghai) Co., Ltd. (CN) | 2024-07-03 | — | — | EP | disclosed |
| US-20240182476-A1 | DIACYLGLYCEROL KINASE MODULATING COMPOUNDS | GILEAD SCIENCES, INC. | 2024-06-06 | — | — | US | disclosed |
| CN-114423742-B | Benzotriazole-based compound, light absorber and resin composition | 三井化学株式会社 | 2024-05-28 | — | — | CN | disclosed |
| CN-115722266-B | Azacarbene-amino-ruthenium catalyst, and preparation method and application thereof | 广东药科大学 | 2024-04-05 | — | — | CN | disclosed |
| CN-117736207-A | Diacylglycerol kinase modulating compounds | 卡尔那生物科学株式会社 | 2024-03-22 | — | — | CN | disclosed |
| CN-115362003-B | Diacylglycerol kinase modulating compounds | 卡尔那生物科学株式会社 | 2024-03-22 | — | — | CN | disclosed |
| CN-117623935-A | Method for preparing amine compound by reductive amination of molecular sieve-based metal catalyst | 浙江大学 | 2024-03-01 | — | — | CN | disclosed |
| CN-114409493-B | Method for synthesizing 9-aryl fluorene compound | 浙江工业大学 | 2024-02-23 | — | — | CN | disclosed |
| EP-4320131-A1 | PROCESS FOR PREPARING ISOHEXIDE DIAMINES FROM ISOHEXIDE DIOLS | Covestro Deutschland AG (DE) | 2024-02-14 | — | — | EP | disclosed |
| CN-117466830-A | Benzotriazole-based compound, light absorber and resin composition | 三井化学株式会社 | 2024-01-30 | — | — | CN | disclosed |
| US-20240024266-A1 | Therapeutic Agent or Prophylactic Agent for COVID-19 | HIROSHIMA UNIVERSITY (JP) | 2024-01-25 | — | — | US | disclosed |
| US-20240024266-A1 | Therapeutic Agent or Prophylactic Agent for COVID-19 | HIROSHIMA UNIVERSITY (JP) | 2024-01-25 | — | — | US | disclosed |
| WO-2024005030-A1 | DIPHENYLETHENE-BASED COMPOUND, LIGHT ABSORBER, RESIN COMPOSITION, AND USE THEREOF | 山本化成株式会社 | 2024-01-04 | — | — | WO | disclosed |
| CN-117285504-A | Amino phenylacetamide derivative and preparation method and application thereof | 桂林医学院 | 2023-12-26 | — | — | CN | disclosed |
| US-11845723-B2 | Diacylglycerol kinase modulating compounds | GILEAD SCIENCES, INC. (US) | 2023-12-19 | — | — | US | disclosed |
| US-20230403869-A1 | PEROVSKITE SOLAR CELL AND FABRICATION METHOD THEREOF | CONTEMPORARY AMPEREX TECHNOLOGY (HONG KONG) LIMITED (CN) | 2023-12-14 | — | — | US | disclosed |
| WO-2023222682-A1 | PROSTATE SPECIFIC MEMBRANE ANTIGEN (PSMA) LIGANDS | Deutsches Krebsforschungszentrum Stiftung des öffentlichen Rechts (DE) | 2023-11-23 | — | — | WO | disclosed |
| US-20230355609-A1 | Spirolactone Compounds | QUIXGEN, INC. (US) | 2023-11-09 | — | — | US | disclosed |
| CN-116969930-A | Thiazole ring-containing pyrazole carboxamide derivative and preparation method and application thereof | 安徽农业大学 | 2023-10-31 | — | — | CN | disclosed |
| CN-116903518-A | Synthesis method of N-methyl-4, 5-benzindole | 太原理工大学 | 2023-10-20 | — | — | CN | disclosed |
| CN-116903518-A | Synthesis method of N-methyl-4, 5-benzindole | 太原理工大学 | 2023-10-20 | — | — | CN | disclosed |
| US-20230322656-A1 | ORGANIC COMPOUND, AND ELECTRONIC COMPONENT AND ELECTRONIC DEVICE HAVING SAME | SHAANXI LIGHTE OPTOELECTRONICS MATERIAL CO., LTD. (CN) | 2023-10-12 | — | — | US | disclosed |
| WO-2022183008-A9 | AMINO-BENZIMIDAZOLE CATALYSTS FOR THE PREPARATION OF POLYOLEFINS | DOW GLOBAL TECHNOLOGIES LLC (US) | 2023-10-12 | — | — | WO | disclosed |
| WO-2023192960-A1 | STAT MODULATORS AND USES THEREOF | RECLUDIX PHARMA, INC. (US) | 2023-10-05 | — | — | WO | disclosed |
| US-20230303537-A1 | NITROGEN-CONTAINING COMPOUND, AND ELECTRONIC ELEMENT AND ELECTRONIC DEVICE THEREOF | SHAANXI LIGHTE OPTOELECTRONICS MATERIAL CO., LTD. (CN) | 2023-09-28 | — | — | US | disclosed |
| US-11767291-B2 | Preparation of secondary amines with electrophilic N-linchpin reagents | WILLIAM MARSH RICE UNIVERSITY (US) | 2023-09-26 | — | — | US | disclosed |
| US-20230301182-A1 | ORGANIC COMPOUND, AND ELECTRONIC ELEMENT AND ELECTRONIC DEVICE USING SAME | SHAANXI LIGHTE OPTOELECTRONICS MATERIAL CO., LTD. (CN) | 2023-09-21 | — | — | US | disclosed |
| WO-2023168240-A1 | SMALL MOLECULE INHIBITORS OF ENPP1 | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2023-09-07 | — | — | WO | disclosed |
| WO-2023160187-A1 | CARBAZOLE DERIVATIVE AND USE THEREOF | 上海八亿时空先进材料有限公司 | 2023-08-31 | — | — | WO | disclosed |
| US-20230260716-A1 | ELECTROLYTIC CAPACITOR | PANASONIC INTELLECTUAL PROPERTY MANAGEMENT CO., LTD. (JP) | 2023-08-17 | — | — | US | disclosed |
| US-20230250048-A1 | NITROGEN-CONTAINING COMPOUND, ELECTRONIC ELEMENT AND ELECTRONIC DEVICE | SHAANXI LIGHTE OPTOELECTRONICS MATERIAL CO., LTD. (CN) | 2023-08-10 | — | — | US | disclosed |
| WO-2023138254-A1 | HETEROCYCLIC COMPOUND, AND ORGANIC ELECTROLUMINESCENT MATERIAL AND ELEMENT | 上海八亿时空先进材料有限公司 | 2023-07-27 | — | — | WO | disclosed |
| WO-2023133336-A1 | STAT MODULATORS AND USES THEREOF | RECLUDIX PHARMA, INC. (US) | 2023-07-13 | — | — | WO | disclosed |
| US-20230203048-A1 | SPIROPYRROLIDINE DERIVED ANTIVIRAL AGENTS | ENANTA PHARMACEUTICALS, INC. | 2023-06-29 | — | — | US | disclosed |
| US-20230203048-A1 | SPIROPYRROLIDINE DERIVED ANTIVIRAL AGENTS | ENANTA PHARMACEUTICALS, INC. | 2023-06-29 | — | — | US | disclosed |
| CN-116283683-A | Method for synthesizing diaryl thioether amine compound by photoinduction catalysis | 衡阳师范学院 | 2023-06-23 | — | — | CN | disclosed |
| US-20230200209-A1 | ORGANOMETALLIC COMPOUND AND ORGANIC LIGHT-EMITTING DIODE INCLUDING THE SAME | LG DISPLAY CO., LTD. (KR) | 2023-06-22 | — | — | US | disclosed |
| US-20230200227-A1 | ORGANIC ELECTROLUMINESCENT DEVICE | Beijing Summer Sprout Technology Co., Ltd. (CN) | 2023-06-22 | — | — | US | disclosed |
| WO-2023087557-A1 | ORGANIC ELECTROLUMINESCENT DEVICE AND ELECTRONIC DEVICE | 陕西莱特光电材料股份有限公司 | 2023-05-25 | — | — | WO | disclosed |
| CN-111704591-B | Synthesis method of copper-catalyzed thionaphthothiazolone compound | 衡阳师范学院 | 2023-05-16 | — | — | CN | disclosed |
| US-20230133581-A1 | Novel 3,5-Diaminobenzoic Acid Compound, and PIN1 Inhibitor and Therapeutic Agent for Inflammatory Diseases Using Same | HIROSHIMA UNIVERSITY (JP) | 2023-05-04 | — | — | US | disclosed |
| US-20230133581-A1 | Novel 3,5-Diaminobenzoic Acid Compound, and PIN1 Inhibitor and Therapeutic Agent for Inflammatory Diseases Using Same | HIROSHIMA UNIVERSITY (JP) | 2023-05-04 | — | — | US | disclosed |
| US-20230122957-A1 | PSMA LIGANDS FOR IMAGING AND ENDORADIOTHERAPY | Technische Universität München (DE) | 2023-04-20 | — | — | US | disclosed |
| CN-115836367-A | Electrolytic capacitor | 松下知识产权经营株式会社 | 2023-03-21 | — | — | CN | disclosed |
| CN-115722266-A | Novel aza-carbene-amido-ruthenium catalyst and preparation method and application thereof | 广东药科大学 | 2023-03-03 | — | — | CN | disclosed |
| EP-4119165-A1 | NOVEL 3,5-DIAMINOBENZOIC ACID COMPOUND, AND PIN1 INHIBITOR AND THERAPEUTIC AGENT FOR INFLAMMATORY DISEASES USING SAME | Hiroshima University (JP) | 2023-01-18 | — | — | EP | disclosed |
| CN-115362003-A | Diacylglycerol kinase modulating compounds | 卡尔那生物科学株式会社 | 2022-11-18 | — | — | CN | disclosed |
| EP-4081305-A1 | DIACYLGLYCEROL KINASE MODULATING COMPOUNDS | Carna Biosciences, Inc. (JP) | 2022-11-02 | — | — | EP | disclosed |
| US-20220324866-A1 | DIACYLGLYCEROL KINASE MODULATING COMPOUNDS | GILEAD SCIENCES, INC. | 2022-10-13 | — | — | US | disclosed |
| WO-2022214469-A1 | PROCESS FOR PREPARING ISOHEXIDE DIAMINES FROM ISOHEXIDE DIOLS | COVESTRO DEUTSCHLAND AG (DE) | 2022-10-13 | — | — | WO | disclosed |
| US-11370740-B2 | Method for producing ester group-containing compound | DIC CORPORATION (JP) | 2022-06-28 | — | — | US | disclosed |
| CN-114423742-A | Benzotriazole compound, light absorber, and resin composition | 三井化学株式会社 | 2022-04-29 | — | — | CN | disclosed |
| CN-114409493-A | Method for synthesizing 9-aryl fluorene compound | 浙江工业大学 | 2022-04-29 | — | — | CN | disclosed |
| WO-2022025189-A1 | ELECTROLYTIC CAPACITOR | パナソニックＩＰマネジメント株式会社 | 2022-02-03 | — | — | WO | disclosed |
| CN-109651208-B | N-aryl sulfonamide compound, pharmaceutical composition and application thereof | 中国科学院上海药物研究所 | 2022-01-04 | — | — | CN | disclosed |
| CN-109336887-B | Benzimidazole chiral heterocyclic compound and preparation method and application thereof | 中山大学 | 2021-12-17 | — | — | CN | disclosed |
| US-20210351358-A1 | ORGANIC ELECTROLUMINESCENT DEVICE | ROHM AND HAAS ELECTRONIC MATERIALS KOREA LTD. (KR) | 2021-11-11 | — | — | US | disclosed |
| CN-109420525-B | Metal iridium catalyst of 2, 2' -bis-benzimidazole ligand and method for synthesizing N-methylated primary amine by using metal iridium catalyst | 南京理工大学 | 2021-10-08 | — | — | CN | disclosed |
| US-11130780-B2 | Inhibitors of growth factor activation enzymes | WASHINGTON UNIVERSITY (US) | 2021-09-28 | — | — | US | disclosed |
| WO-2021149767-A1 | HETEROCYCLIC DERIVATIVE | 大日本住友製薬株式会社 | 2021-07-29 | — | — | WO | disclosed |
| US-11066749-B2 | Corrosion inhibition of HCL treatment fluids with environmentally compatible solvent | HALLIBURTON ENERGY SERVICES, INC. (US) | 2021-07-20 | — | — | US | disclosed |
| US-20210214542-A1 | NOVEL AMINE FUNCTIONALIZED POLYMERS AND METHODS OF PREPARATION | THE UNIVERSITY OF BRITISH COLUMBIA (CA) | 2021-07-15 | — | — | US | disclosed |
| WO-2021054459-A1 | BENZOTRIAZOLE COMPOUND, LIGHT ABSORBER, AND RESIN COMPOSITION | 三井化学株式会社 | 2021-03-25 | — | — | WO | disclosed |
| CN-109836365-B | Amine thioacyl fluoride derivatives and synthetic method thereof | 华东师范大学 | 2021-02-26 | — | — | CN | disclosed |
| EP-3564249-B1 | NOVEL COMPOUND AND ORGANIC LIGHT EMITTING DEVICE USING SAME | LG CHEMICAL LTD (KR) | 2021-01-20 | — | — | EP | disclosed |
| US-20200383987-A1 | Novel Amide Compound, and Pin1 Inhibitor, Therapeutic Agent for Inflammatory Diseases and Therapeutic Agent for Cancer That Use the Same | HIROSHIMA UNIVERSITY (JP) | 2020-12-10 | — | — | US | disclosed |
| EP-3122353-B1 | SUBSTITUTED INDOLE MCL-1 INHIBITORS | UNIV VANDERBILT (US) | 2020-10-28 | — | — | EP | disclosed |
| CN-111704591-A | Synthesis method of copper-catalyzed thio-naphthothiazolone compound | 衡阳师范学院 | 2020-09-25 | — | — | CN | disclosed |
| US-20200297876-A1 | PSMA ligands for imaging and endoradiotherapy | Technische Universität München (DE) | 2020-09-24 | — | — | US | disclosed |
| WO-2020165420-A1 | PROSTATE SPECIFIC MEMBRANE ANTIGEN (PSMA) LIGANDS WITH IMPROVED TISSUE SPECIFICITY | Ruprecht-Karls-Universität Heidelberg (DE) | 2020-08-20 | — | — | WO | disclosed |
| US-20200199453-A1 | POLYMERISABLE LIQUID CRYSTAL MATERIAL AND POLYMERISED LIQUID CRYSTAL FILM | MERCK PATENT GMBH (DE) | 2020-06-25 | — | — | US | disclosed |
| US-20200173034-A1 | Corrosion Inhibition of HCL Treatment Fluids with Environmentally Compatible Solvent | HALLIBURTON ENERGY SERVICES, INC. (US) | 2020-06-04 | — | — | US | disclosed |
| CN-107417623-B | Method for synthesizing 5-diarylaminobenzimidazole derivative in one step | 华南理工大学 | 2020-05-22 | — | — | CN | disclosed |
| US-10649124-B2 | Composition including compound having mesogenic group, polymer and optically anisotropic body obtained by polymerizing polymerizable composition, and phase difference film | DIC CORPORATION (JP) | 2020-05-12 | — | — | US | disclosed |
| EP-3030569-B1 | SILANE AND SILICIC ACID (HETERO)POLYCONDENSATE HAVING AROMATIC COMPOUNDS LINKED VIA COUPLING GROUPS WHICH ARE SUITABLE AS OR FOR MATRIX SYSTEMS HAVING HIGH TRANSLUCENCY AND GOOD MECHANICAL PROPERTIES | WOLTER HERBERT (DE) | 2020-05-06 | — | — | EP | disclosed |
| US-10604850-B2 | Corrosion inhibition of HCL treatment fluids with environmentally compatible solvent | HALLIBURTON ENERGY SERVICES, INC. (US) | 2020-03-31 | — | — | US | disclosed |
| WO-2020040157-A1 | COMPOSITION FOR DENTAL MATERIAL, DENTAL MATERIAL, AND MICROFIBROUS CELLULOSE USED IN DENTAL MATERIAL | 王子ホールディングス株式会社 | 2020-02-27 | — | — | WO | disclosed |
| WO-2020017587-A1 | PYRIDAZINONE DERIVATIVE | 大日本住友製薬株式会社 | 2020-01-23 | — | — | WO | disclosed |
| WO-2019147015-A1 | EFFICIENT SYNTHESIS METHOD OF C20 POLYENE BIS(PHOSPHONATE) AND CAROTENE COMPOUND USING SAME | 명지대학교 산학협력단 | 2019-08-01 | — | — | WO | disclosed |
| EP-2551270-B1 | PYRAZOLOPYRIMIDINE DERIVATIVES FOR USE AS PI3 KINASE ANTAGONISTS | UNIV CALIFORNIA (US) | 2019-06-12 | — | — | EP | disclosed |
| CN-109836365-A | The thio acyl fluorides derivative of a kind of amine and its synthetic method | 华东师范大学 | 2019-06-04 | — | — | CN | disclosed |
| EP-3489390-A1 | ELECTROCHEMICAL METHOD FOR O-C COUPLING OF UNPROTECTED PHENOLS WITH OPTICALLY PURE ARYLAMINES | Evonik Degussa GmbH (DE) | 2019-05-29 | — | — | EP | disclosed |
| EP-3483146-A1 | HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING DEVICE USING SAME | Heesung Material Ltd. (KR) | 2019-05-15 | — | — | EP | disclosed |
| EP-2949655-B1 | REACTION CATALYST FOR CROSS COUPLING AND METHOD FOR MANUFACTURING AROMATIC COMPOUND | HOKKO CHEM IND CO (JP) | 2019-05-15 | — | — | EP | disclosed |
| CN-109651208-A | N- arylsulfonamides compound, medical composition and its use | 中国科学院上海药物研究所 | 2019-04-19 | — | — | CN | disclosed |
| EP-3212694-B1 | SILANES AND SILICIC ACID (HETERO) POLYCONDENSATES SUBSTITUTED WITH AROMATIC RESIDUES AND WITH HYDROXY GROUPS, AND DERIVATIVES THEREOF, WHICH ARE SUITABLE, AS SUCH OR AS COMPOSITES, FOR (MATRIX) SYSTEMS HAVING HIGH TRANSLUCENCE AND GOOD MECHANICAL PROPERTIES | WOLTER HERBERT (DE) | 2019-03-27 | — | — | EP | disclosed |
| EP-2427451-B1 | ALPHA HELIX MIMETICS AND METHODS RELATING THERETO | PRISM BIOLAB CO LTD (JP) | 2019-03-20 | — | — | EP | disclosed |
| US-10227364-B2 | Silane and silicic acid (hetero)polycondensate having aromatic compounds linked via coupling groups which are suitable as or for matrix systems having high translucency and good mechanical properties | FRAUNHOFER-GESELLSCHAFT ZUR FOERDERUNG DER ANGEWANDTEN FORSCHUNG E.V. (DE) | 2019-03-12 | — | — | US | disclosed |
| CN-109420525-A | The method of the metal iridium catalyst and its synthesis N- methylation primary amine of 2,2 '-bisbenzimidazole ligands | 南京理工大学 | 2019-03-05 | — | — | CN | disclosed |
| US-10208000-B2 | Eis inhibitors | UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION (US) | 2019-02-19 | — | — | US | disclosed |
| CN-109336887-A | A kind of benzimidazole and chiral heterocycle class compound and its preparation method and application | 中山大学 | 2019-02-15 | — | — | CN | disclosed |
| US-10202353-B2 | Therapeutic compounds | GILEAD SCIENCES, INC. (US) | 2019-02-12 | — | — | US | disclosed |
| US-20190025490-A1 | COMPOSITION INCLUDING COMPOUND HAVING MESOGENIC GROUP, POLYMER AND OPTICALLY ANISOTROPIC BODY OBTAINED BY POLYMERIZING POLYMERIZABLE COMPOSITION, AND PHASE DIFFERENCE FILM | DIC CORPORATION (JP) | 2019-01-24 | — | — | US | disclosed |
| WO-2018100159-A1 | BACTERIAL GLUTAMINYL CYCLASES AND INHIBITORS THEREOF FOR USE IN THE TREATMENT OF PERIODONTITIS | Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. (DE) | 2018-06-07 | — | — | WO | disclosed |
| CN-105008378-B | The manufacturing method of cross-coupling catalysts and aromatic compound | 北兴化学工业株式会社 | 2018-05-18 | — | — | CN | disclosed |
| US-20180127882-A1 | Corrosion Inhibition of HCL Treatment Fluids with Environmentally Compatible Solvent | HALLIBURTON ENERGY SERVICES, INC. (US) | 2018-05-10 | — | — | US | disclosed |
| US-20180066015-A1 | INHIBITORS OF GROWTH FACTOR ACTIVATION ENZYMES | WASHINGTON UNIVERSITY (US) | 2018-03-08 | — | — | US | disclosed |
| CN-107417623-A | A kind of method of the diarylamino benzimidizole derivatives of one-step synthesis 5 | 华南理工大学 | 2017-12-01 | — | — | CN | disclosed |
| US-9809556-B2 | Treatment of amyotrophic lateral sclerosis | NORTHWESTERN UNIVERSITY (US) | 2017-11-07 | — | — | US | disclosed |
| EP-3225619-A1 | 2-AMINOPYRIMIDINE COMPOUND AND PHARMACEUTICAL COMPOSITION AND USE THEREOF | Shanghai Institute Of Materia Medica Chinese Academy of Sciences (CN) | 2017-10-04 | — | — | EP | disclosed |
| EP-3212694-A1 | SILANES AND SILICIC ACID (HETERO) POLYCONDENSATES SUBSTITUTED WITH AROMATIC RESIDUES AND WITH HYDROXY GROUPS, AND DERIVATIVES THEREOF, WHICH ARE SUITABLE, AS SUCH OR AS COMPOSITES, FOR (MATRIX) SYSTEMS HAVING HIGH TRANSLUCENCE AND GOOD MECHANICAL PROPERTIES | Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. (DE) | 2017-09-06 | — | — | EP | disclosed |
| US-9707551-B2 | Reaction catalyst for cross-coupling and method for manufacturing aromatic compound | HOKKO CHEMICAL INDUSTRY CO., LTD. (JP) | 2017-07-18 | — | — | US | disclosed |
| CN-106928037-A | A kind of preparation method of carvol | 万华化学集团股份有限公司 | 2017-07-07 | — | — | CN | disclosed |
| US-20170189410-A1 | Amino Compounds for Treatment of Complement Mediated Disorders | ACHILLION PHARMACEUTICALS, INC. (US) | 2017-07-06 | — | — | US | disclosed |
| US-9695191-B2 | Conformationally constrained, fully synthetic macrocyclic compounds | POLYPHOR AG (CH) | 2017-07-04 | — | — | US | disclosed |
| US-9688646-B2 | Process for producing N-methyl or N,N-dimethyl amines | Lanxhou Institute of Chemical Physics, Chinese Academy of Sciences (CN) | 2017-06-27 | — | — | US | disclosed |
| US-20170174639-A1 | EIS INHIBITORS | UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION | 2017-06-22 | — | — | US | disclosed |
| WO-2017070560-A1 | COMPOSITIONS AND METHODS OF PROMOTING ORGANIC PHOTOCATALYSIS | THE REGENTS OF THE UNIVERSITY OF COLORADO, A BODY CORPORATE (US) | 2017-04-27 | — | — | WO | disclosed |
| US-9598446-B2 | Amino compounds for treatment of complement mediated disorders | ACHILLION PHARMACEUTICALS, INC. (US) | 2017-03-21 | — | — | US | disclosed |
| CN-106458868-A | Guanidine compounds and uses thereof | 伊谬诺米特医疗有限公司 | 2017-02-22 | — | — | CN | disclosed |
| EP-2499148-B1 | CONFORMATIONALLY CONSTRAINED, FULLY SYNTHETIC MACROCYCLIC COMPOUNDS | POLYPHOR AG (CH) | 2017-01-18 | — | — | EP | disclosed |
| US-20160368881-A1 | THERAPEUTIC COMPOUNDS | GILEAD SCIENCES, INC. | 2016-12-22 | — | — | US | disclosed |
| US-9512139-B2 | Conformationally constrained, fully synthetic macrocyclic compounds | POLYPHOR AG (CH) | 2016-12-06 | — | — | US | disclosed |
| WO-2016190865-A1 | CORROSION INHIBITION OF HCL TREATMENT FLUIDS WITH ENVIRONMENTALLY COMPATIBLE SOLVENT | HALLIBURTON ENERGY SERVICES, INC. (US) | 2016-12-01 | — | — | WO | disclosed |
| US-9499474-B2 | Process for producing arylamines | MERCK PATENT GMBH (DE) | 2016-11-22 | — | — | US | disclosed |
| US-20160194284-A1 | ALLOSTERIC MODULATORS OF THE CANNABINOID 1 RECEPTOR | NORTHEASTERN UNIVERSITY (US) | 2016-07-07 | — | — | US | disclosed |
| US-20160185804-A1 | SILANE AND SILICIC ACID (HETERO)POLYCONDENSATE HAVING AROMATIC COMPOUNDS LINKED VIA COUPLING GROUPS WHICH ARE SUITABLE AS OR FOR MATRIX SYSTEMS HAVING HIGH TRANSLUCENCY AND GOOD MECHANICAL PROPERTIES | FRAUNHOFER-GESELLSCHAFT ZUR FOERDERUNG DER ANGEWANDTEN FORSCHUNG E.V. (DE) | 2016-06-30 | — | — | US | disclosed |
| EP-3030569-A1 | SILANE AND SILICIC ACID (HETERO)POLYCONDENSATE HAVING AROMATIC COMPOUNDS LINKED VIA COUPLING GROUPS WHICH ARE SUITABLE AS OR FOR MATRIX SYSTEMS HAVING HIGH TRANSLUCENCY AND GOOD MECHANICAL PROPERTIES | Fraunhofer Gesellschaft zur Förderung der angewandten Forschung E.V. (DE) | 2016-06-15 | — | — | EP | disclosed |
| WO-2016066653-A1 | SILANES AND SILICIC ACID (HETERO) POLYCONDENSATES SUBSTITUTED WITH AROMATIC RESIDUES AND WITH HYDROXY GROUPS, AND DERIVATIVES THEREOF, WHICH ARE SUITABLE, AS SUCH OR AS COMPOSITES, FOR (MATRIX) SYSTEMS HAVING HIGH TRANSLUCENCE AND GOOD MECHANICAL PROPERTIES | Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. (DE) | 2016-05-06 | — | — | WO | disclosed |
| US-20150360214-A1 | REACTION CATALYST FOR CROSS-COUPLING AND METHOD FOR MANUFACTURING AROMATIC COMPOUND | HOKKO CHEMICAL INDUSTRY CO., LTD. (JP) | 2015-12-17 | — | — | US | disclosed |
| EP-2949655-A1 | REACTION CATALYST FOR CROSS COUPLING AND METHOD FOR MANUFACTURING AROMATIC COMPOUND | Hokko Chemical Industry Co., Ltd. (JP) | 2015-12-02 | — | — | EP | disclosed |
| CN-105008378-A | Reaction catalyst for cross coupling and method for manufacturing aromatic compound | HOKKO CHEM IND CO | 2015-10-28 | — | — | CN | disclosed |
| CN-104922117-A | BETA-LACTAMYLALKANOIC ACIDS FOR TREATING PREMENSTRUAL DISORDERS | AZEVAN PHARMACEUTICALS INC | 2015-09-23 | — | — | CN | disclosed |
| US-20150239894-A1 | Amino Compounds for Treatment of Complement Mediated Disorders | ACHILLION PHARMACEUTICALS, INC. (US) | 2015-08-27 | — | — | US | disclosed |
| CN-103298772-B | Method for producing aromatic alcohol or heterocyclic aromatic alcohol | MITSUBISHI GAS CHEMICAL CO | 2015-06-24 | — | — | CN | disclosed |
| US-9012166-B2 | Method for assaying histone methylation enzyme activity | KYUSHU INSTITUTE OF TECHNOLOGY (JP) | 2015-04-21 | — | — | US | disclosed |
| US-9012166-B2 | Method for assaying histone methylation enzyme activity | KYUSHU INSTITUTE OF TECHNOLOGY (JP) | 2015-04-21 | — | — | US | disclosed |
| US-8962244-B2 | Compounds for modulating RNA binding proteins and uses therefor | UNIVERSITY OF MASSACHUSETTS (US) | 2015-02-24 | — | — | US | disclosed |
| WO-2015018906-A1 | SILANE AND SILICIC ACID (HETERO)POLYCONDENSATE HAVING AROMATIC COMPOUNDS LINKED VIA COUPLING GROUPS WHICH ARE SUITABLE AS OR FOR MATRIX SYSTEMS HAVING HIGH TRANSLUCENCY AND GOOD MECHANICAL PROPERTIES | Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. (DE) | 2015-02-12 | — | — | WO | disclosed |
| CN-104334528-A | (2-heteroarylamino) succinic acid derivatives | DAIICHI SANKYO CO LTD | 2015-02-04 | — | — | CN | disclosed |
| EP-2562264-B1 | METHOD FOR ASSAYING HISTONE METHYLATION ENZYME ACTIVITY | KYUSHU INST TECHNOLOGY (JP) | 2015-01-14 | — | — | EP | disclosed |
| EP-2810944-A1 | HETEROCYCLIC COMPOUND HAVING ANTI-HIV ACTIVITY | Toyama Chemical Co., Ltd. (JP) | 2014-12-10 | — | — | EP | disclosed |
| US-20140309458-A1 | PROCESS FOR PRODUCING ARYLAMINES | MERCK PATENT GMBH (DE) | 2014-10-16 | — | — | US | disclosed |
| EP-2435423-B1 | SUBSTITUTED BENZOTRIAZINES AND QUINOXALINES AS INHIBITORS OF P70S6 KINASE | SENTINEL ONCOLOGY LTD (GB) | 2014-10-15 | — | — | EP | disclosed |
| US-8716473-B2 | Substituted benzotriazines and quinoxalines as inhibitors of P7OS6 kinase | SENTINEL ONCOLOGY LIMITED (GB) | 2014-05-06 | — | — | US | disclosed |
| WO-2014015276-A1 | α-AND γ-TRUXILLIC ACID DERIVATIVES AND PHARMACEUTICAL COMPOSITIONS THEREOF | THE RESEARCH FOUNDATION OF STATE UNIVERSITY OF NEW YORK (US) | 2014-01-23 | — | — | WO | disclosed |
| CN-103459372-A | Process for preparing cyclic amine compounds | KANEKA CORP | 2013-12-18 | — | — | CN | disclosed |
| US-8569505-B2 | Aminotetralin-derived urea modulators of vanilloid VR1 receptor | JANSSEN PHARMACEUTICA, NV (BE) | 2013-10-29 | — | — | US | disclosed |
| EP-2646600-A1 | CORROSION INHIBITOR COMPOSITIONS COMPRISING REACTION PRODUCTS OF ALDEHYDES AND AMIDES AND RELATED METHODS | Halliburton Energy Services, Inc. (US) | 2013-10-09 | — | — | EP | disclosed |
| CN-103298772-A | Method for producing aromatic alcohol or heterocyclic aromatic alcohol | MITSUBISHI GAS CHEMICAL CO | 2013-09-11 | — | — | CN | disclosed |
| CN-103269584-A | Methods for treating post-traumatic stress disorder | AZEVAN PHARMACEUTICALS INC | 2013-08-28 | — | — | CN | disclosed |
| US-20130217685-A1 | COMPOUNDS FOR MODULATING RNA BINDING PROTEINS AND USES THEREFOR | UNIVERSITY OF MASSACHUSETTS (US) | 2013-08-22 | — | — | US | disclosed |
| US-8377639-B2 | Compounds for modulating RNA binding proteins and uses therefor | UNIVERSITY OF MASSACHUSETTS (US) | 2013-02-19 | — | — | US | disclosed |
| US-20130029878-A1 | Method for Assaying Histone Methylation Enzyme Activity | KYUSHU INSTITUTE OF TECHNOLOGY (JP) | 2013-01-31 | — | — | US | disclosed |
| US-20130029878-A1 | Method for Assaying Histone Methylation Enzyme Activity | KYUSHU INSTITUTE OF TECHNOLOGY (JP) | 2013-01-31 | — | — | US | disclosed |
| US-8361937-B2 | Corrosion inhibitor compositions comprising reaction products of aldehydes and amides and related methods | HALLIBURTON ENERGY SERVICES, INC. (US) | 2013-01-29 | — | — | US | disclosed |
| US-20120202821-A1 | CONFORMATIONALLY CONSTRAINED, FULLY SYNTHETIC MACROCYCLIC COMPOUNDS | POLYPHOR AG (CH) | 2012-08-09 | — | — | US | disclosed |
| WO-2012072986-A1 | CORROSION INHIBITOR COMPOSITIONS COMPRISING REACTION PRODUCTS OF ALDEHYDES AND AMIDES AND RELATED METHODS | HALLIBURTON ENERGY SERVICES, INC. (US) | 2012-06-07 | — | — | WO | disclosed |
| US-20120142563-A1 | Corrosion Inhibitor Compositions Comprising Reaction Products of Aldehydes and Amides and Related Methods | HALLIBURTON ENERGY SERVICES, INC. (US) | 2012-06-07 | — | — | US | disclosed |
| US-20120071478-A1 | SUBSTITUTED BENZOTRIAZINES AND QUINOXALINES AS INHIBITORS OF P7OS6 KINASE | SENTINEL ONCOLOGY LIMITED (GB) | 2012-03-22 | — | — | US | disclosed |
| US-20120053345-A1 | Indazole Compounds | ABBOTT LABORATORIES (US) | 2012-03-01 | — | — | US | disclosed |
| EP-1506166-B1 | AMINOTETRALIN-DERIVED UREA MODULATORS OF VANILLOID VR1 RECEPTOR | JANSSEN PHARMACEUTICA NV (BE) | 2011-11-16 | — | — | EP | disclosed |
| WO-2011131712-A1 | METAL HYBRID COMPOSITE CASTING | Rheinisch-Westfälische Technische Hochschule Aachen (DE) | 2011-10-27 | — | — | WO | disclosed |
| US-8008481-B2 | Indazole compounds | ABBVIE INC. | 2011-08-30 | — | — | US | disclosed |
| EP-0853618-B1 | SUBSTITUTED (SULFINIC ACID, SULFONIC ACID, SULFONYLAMINO OR SULFINYLAMINO) N- (AMINOIMINOMETHYL)PHENYLALKYL -AZAHETEROCYCLYLAMIDE COMPOUNDS | AVENTIS PHARMA INC (US) | 2011-08-17 | — | — | EP | disclosed |
| EP-2357169-A1 | Isoindolone compounds and their use as metabotropic glutamate receptor potentiators | AstraZeneca AB (SE) | 2011-08-17 | — | — | EP | disclosed |
| US-20110195999-A1 | NOVEL ANTIFUNGAL AGENT CONTAINING HETEROCYCLIC COMPOUND | NAKAMOTO KAZUTAKA | 2011-08-11 | — | — | US | disclosed |
| CN-101001886-B | Redox curing-type nonaqueous curable composition | KURARAY MEDICAL INC | 2011-07-13 | — | — | CN | disclosed |
| US-7968570-B2 | Isoindolone compounds and their use as metabotropic glutamate receptor potentiators | ASTRAZENECA AB (SE) | 2011-06-28 | — | — | US | disclosed |
| US-7932272-B2 | Antifungal agent containing heterocyclic compound | EISAI R&D MANAGEMENT CO., LTD. (JP) | 2011-04-26 | — | — | US | disclosed |
| CN-1863784-B | 2-naphthylimino-1,3-thiazine derivative | SHIONOGI & CO | 2010-11-17 | — | — | CN | disclosed |
| EP-1028942-B1 | DIPEPTIDE NITRILES | NOVARTIS AG (CH) | 2010-09-01 | — | — | EP | disclosed |
| US-20100125140-A1 | AMINOTETRALIN-DERIVED UREA MODULATORS OF VANILLOID VR1 RECEPTOR | CODD ELLEN | 2010-05-20 | — | — | US | disclosed |
| US-7678812-B2 | Aminotetralin-derived urea modulators of vanilloid VR1 receptor | JANSSEN PHARMACEUTICA NV (BE) | 2010-03-16 | — | — | US | disclosed |
| US-7662960-B2 | Beta-strand mimetics and method relating thereto | CHOONGWAE PHARMA CORPORATION (KR) | 2010-02-16 | — | — | US | disclosed |
| EP-1919896-B1 | AMINOARYL SULPHONAMIDE DERIVATIVES AS FUNCTIONAL 5-HT6 LIGANDS. | SUVEN LIFE SCIENCES LTD (IN) | 2009-12-23 | — | — | EP | disclosed |
| US-20090275578-A1 | Isoindolone compounds and their use as metabotropic glutamate receptor potentiators | ASTRAZENECA AB (SE) | 2009-11-05 | — | — | US | disclosed |
| US-20090227799-A1 | Novel Antimalarial Agent Containing Heterocyclic Compound | EISAI R&D MANAGEMENT CO., LTD. (JP) | 2009-09-10 | — | — | US | disclosed |
| US-7553340-B2 | Reactive dyes, a process for their preparation and their use | HUNTSMAN INTERNATIONAL, LLC (US) | 2009-06-30 | — | — | US | disclosed |
| CN-100467458-C | Indanyl-piperazine derivatives, process for their preparation and pharmaceutical compositions containing them | SERVIER LAB CO LTD (FR) | 2009-03-11 | — | — | CN | disclosed |
| WO-2008098857-A1 | 2-AMINOOXAZOLINES AS TAAR1 LIGANDS | F. HOFFMANN-LA ROCHE AG (CH) | 2008-08-21 | — | — | WO | disclosed |
| US-7399884-B2 | Histone deacetylase inhibitors | TAKEDA SAN DIEGO, INC. (US) | 2008-07-15 | — | — | US | disclosed |
| CN-101208010-A | Beta-lactamylalkanoic acids for the treatment of premenstrual disorders | AZEVAN PHARMACEUTICALS INC (US) | 2008-06-25 | — | — | CN | disclosed |
| US-7390822-B2 | Substituted 4-phenyl-4-[1H-imidazol-2-yl]-piperidine derivatives for reducing ischaemic damage | JANSSEN PHARMACEUTICA, N.V. (BE) | 2008-06-24 | — | — | US | disclosed |
| US-7390822-B2 | Substituted 4-phenyl-4-[1H-imidazol-2-yl]-piperidine derivatives for reducing ischaemic damage | JANSSEN PHARMACEUTICA, N.V. (BE) | 2008-06-24 | — | — | US | disclosed |
| US-20080097102-A1 | AMINOTETRALIN-DERIVED UREA MODULATORS OF VANILLOID VR1 RECEPTOR | CODD ELLEN | 2008-04-24 | — | — | US | disclosed |
| US-20080096925-A1 | Novel Substituted 4-Phenyl-4[H-Imidazol-2-YL]-Piperidine Derivatived And Their Use As Selective Non-Peptide Delta Opioid Agonists | JANSSEN PHARMACEUTICA N.V. (BE) | 2008-04-24 | — | — | US | disclosed |
| US-20080096925-A1 | Novel Substituted 4-Phenyl-4[H-Imidazol-2-YL]-Piperidine Derivatived And Their Use As Selective Non-Peptide Delta Opioid Agonists | JANSSEN PHARMACEUTICA N.V. (BE) | 2008-04-24 | — | — | US | disclosed |
| US-20080027060-A1 | DIPEPTIDE NITRILES | ALTMANN EVA | 2008-01-31 | — | — | US | disclosed |
| US-20080027060-A1 | DIPEPTIDE NITRILES | ALTMANN EVA | 2008-01-31 | — | — | US | disclosed |
| EP-1549598-A4 | NAPTHTHALENE DERIVATIVES WHICH INHIBIT THE CYTOKINE OR BIOLOGICAL ACTIVITY OF MACROPHAGE MIGRATION INHIBITORY FACTOR (MIF) | CORTICAL PTY LTD (AU) | 2008-01-23 | — | — | EP | disclosed |
| US-20070294842-A1 | Reactive Dyes, a Process for Their Preparation and Their Use | HUNTSMAN INTERNATIONAL LLC | 2007-12-27 | — | — | US | disclosed |
| US-20070282101-A1 | Indazole compounds | ABBVIE INC. | 2007-12-06 | — | — | US | disclosed |
| US-7282508-B2 | Substituted 4-phenyl-4-(1H-imidazol-2-yl)-piperidine derivatives and their use as selective non-peptide delta opioid agonists | JANSSEN PHARMACEUTICA N.V. (BE) | 2007-10-16 | — | — | US | disclosed |
| US-7282508-B2 | Substituted 4-phenyl-4-(1H-imidazol-2-yl)-piperidine derivatives and their use as selective non-peptide delta opioid agonists | JANSSEN PHARMACEUTICA N.V. (BE) | 2007-10-16 | — | — | US | disclosed |
| CN-101001886-A | Redox curing-type nonaqueous curable composition | KURARAY MEDICAL INC (JP) | 2007-07-18 | — | — | CN | disclosed |
| US-20070149495-A1 | HISTONE DEACETYLASE INHIBITORS | TAKEDA SAN DIEGO, INC. (US) | 2007-06-28 | — | — | US | disclosed |
| US-20070105943-A1 | Novel antifungal agent containing heterocyclic compound | EISAI R&D MANAGEMENT CO., LTD. (JP) | 2007-05-10 | — | — | US | disclosed |
| EP-1782811-A1 | NOVEL ANTIMALARIA AGENT CONTAINING HETEROCYCLIC COMPOUND | Eisai R&D Management Co., Ltd. (JP) | 2007-05-09 | — | — | EP | disclosed |
| EP-1778634-A1 | ISOINDOLONE COMPOUNDS AND THEIR USE AS METABOTROPIC GLUTAMATE RECEPTOR POTENTIATORS | AstraZeneca AB (SE) | 2007-05-02 | — | — | EP | disclosed |
| US-7173032-B2 | Methods and compositions of novel triazine compounds | REDDY US THERAPEUTICS, INC. (US) | 2007-02-06 | — | — | US | disclosed |
| US-7173032-B2 | Methods and compositions of novel triazine compounds | REDDY US THERAPEUTICS, INC. (US) | 2007-02-06 | — | — | US | disclosed |
| CN-1874991-A | Compounds capable of binding to the S1P receptor and pharmaceutical uses thereof | ONO PHARMACEUTICAL CO (JP) | 2006-12-06 | — | — | CN | disclosed |
| CN-1867339-A | Novel use of cannabinoid receptor antagonists | SHIONOGI & CO (JP) | 2006-11-22 | — | — | CN | disclosed |
| CN-1863784-A | 2-naphthylimino-1,3-thiazine derivative | SHIONOGI & CO (JP) | 2006-11-15 | — | — | CN | disclosed |
| EP-1194144-B1 | ANTIBACTERIAL COMPOUNDS | AFFINIUM PHARM INC (CA) | 2006-11-02 | — | — | EP | disclosed |
| CN-1840527-A | Indanyl-piperazine derivatives, process for their preparation and pharmaceutical compositions containing them | SERVIER LAB (FR) | 2006-10-04 | — | — | CN | disclosed |
| EP-1669348-A1 | NOVEL ANTIFUNGAL AGENT COMPRISING HETEROCYCLIC COMPOUND | Eisai Co., Ltd. (JP) | 2006-06-14 | — | — | EP | disclosed |
| CN-1255386-C | Substituted fused heterocyclic compound | SANKYO CO (JP) | 2006-05-10 | — | — | CN | disclosed |
| CN-1250189-C | Tooth cement agent composition | KURARAY CO (JP) | 2006-04-12 | — | — | CN | disclosed |
| CN-1247553-C | 2-imino-1,3-thiazine derivs. | SHIONOGI & CO (JP) | 2006-03-29 | — | — | CN | disclosed |
| CN-1245931-C | Composition reagent box for dentistry | KURARAY CO (JP) | 2006-03-22 | — | — | CN | disclosed |
| WO-2006020879-A1 | ISOINDOLONE COMPOUNDS AND THEIR USE AS METABOTROPIC GLUTAMATE RECEPTOR POTENTIATORS | ASTRAZENECA AB (SE) | 2006-02-23 | — | — | WO | disclosed |
| CN-1729159-A | Amide compounds and methods for controlling plant diseases | SUMITOMO CHEMICAL CO (JP) | 2006-02-01 | — | — | CN | disclosed |
| EP-1615890-A1 | PIPERIDINE DERIVATIVES AS RENIN INHIBITORS FOR THE TREATMENT OF HYPERTENSION | WARNER-LAMBERT COMPANY (US) | 2006-01-18 | — | — | EP | disclosed |
| US-6984647-B2 | Aminotetralin-derived urea modulators of vanilloid VR1 receptor | JANSSEN PHARMACEUTICA N.V. (BE) | 2006-01-10 | — | — | US | disclosed |
| US-6984673-B2 | Dental cement composition | KURARAY CO., LTD. (JP) | 2006-01-10 | — | — | US | disclosed |
| WO-2004089903-A9 | PIPERIDINE DERIVATIVES AS RENIN INHIBITORS FOR THE TREATMENT OF HYPERTENSION | WARNER LAMBERT CO (US) | 2005-10-27 | — | — | WO | disclosed |
| EP-1269968-B1 | Dental cement composition | KURARAY CO (JP) | 2005-10-12 | — | — | EP | disclosed |
| EP-1577290-A1 | AMIDE COMPOUND AND METHOD OF CONTROLLING PLANT DISEASE WITH THE SAME | Sumitomo Chemical Company, Limited (JP) | 2005-09-21 | — | — | EP | disclosed |
| US-6943256-B2 | Chiral organic compounds and metal coordination complexes thereof | INDIANA UNIVERSITY RESEARCH AND TECHNOLOGY CORPORATION (US) | 2005-09-13 | — | — | US | disclosed |
| US-20050187291-A1 | use of 2-(urea or thiourea)tetralins as analgesic or to treat pulmonary dysfunction | JANSSEN PHARMACEUTICA, N.V. (BE) | 2005-08-25 | — | — | US | disclosed |
| EP-1549598-A1 | NAPTHTHALENE DERIVATIVES WHICH INHIBIT THE CYTOKINE OR BIOLOGICAL ACTIVITY OF MACROPHAGE MIGRATION INHIBITORY FACTOR (MIF) | Cortical Pty Ltd (AU) | 2005-07-06 | — | — | EP | disclosed |
| EP-1269967-B1 | Dental composition kit | KURARAY CO (JP) | 2005-05-18 | — | — | EP | disclosed |
| US-6869984-B2 | Dental composition kit | KURARAY CO., LTD. (JP) | 2005-03-22 | — | — | US | disclosed |
| EP-1506166-A1 | AMINOTETRALIN-DERIVED UREA MODULATORS OF VANILLOID VR1 RECEPTOR | JANSSEN PHARMACEUTICA N.V. (BE) | 2005-02-16 | — | — | EP | disclosed |
| CN-1188407-C | Imidazole derivatives with inhabiting activity to transterasa and preparing method thereof | LG CHEMICAL LTD (KR) | 2005-02-09 | — | — | CN | disclosed |
| CN-1553897-A | Dolastatin 10 derivatives | - | 2004-12-08 | — | — | CN | disclosed |
| WO-2004089903-A1 | PIPERIDINE DERIVATIVES AS RENIN INHIBITORS FOR THE TREATMENT OF HYPERTENSION | WARNER-LAMBERT COMPANY LLC (US) | 2004-10-21 | — | — | WO | disclosed |
| US-20040204455-A1 | Piperidine derivative rennin inhibitors | WARNER-LAMBERT COMPANY LLC | 2004-10-14 | — | — | US | disclosed |
| CN-1161356-C | Puring inhibitors of cylin dependent kinase 2 and I'kappa'beta-'alpha' | CV���ƹ�˾ | 2004-08-11 | — | — | CN | disclosed |
| US-20040143118-A1 | Chiral organic compounds and metal coordination complexes thereof | ADVANCED RESEARCH & TECHNOLOGY INSTITUTE, INC. | 2004-07-22 | — | — | US | disclosed |
| US-6673941-B2 | Disubstituted imidazoles useful in the treatment of bacterial infections | AFFINIUM PHARMACEUTICALS, INC. (CA) | 2004-01-06 | — | — | US | disclosed |
| US-20030236280-A1 | Aminotetralin-derived urea modulators of vanilloid VR1 receptor | JANSSEN PHARMACEUTICA, N.V. (BE) | 2003-12-25 | — | — | US | disclosed |
| WO-2003104178-A1 | NAPTHTHALENE DERIVATIVES WHICH INHIBIT THE CYTOKINE OR BIOLOGICAL ACTIVITY OF MACROPHAGE MIGRATION INHIBITORY FACTOR (MIF) | CORTICAL PTY LTD (AU) | 2003-12-18 | — | — | WO | disclosed |
| WO-2003097586-A1 | AMINOTETRALIN-DERIVED UREA MODULATORS OF VANILLOID VR1 RECEPTOR | JANSSEN PHARMACEUTICA N.V. (BE) | 2003-11-27 | — | — | WO | disclosed |
| US-6653321-B1 | Stimulating kinase activity of insulin receptor; type II diabetes; hyperglycemia | TELIK, INC. | 2003-11-25 | — | — | US | disclosed |
| EP-0878196-B1 | KAINIC ACID NEURONOTOXICITY INHIBITORS AND PYRIDOTHIAZINE DERIVATIVES | YAMANOUCHI PHARMA CO LTD (JP) | 2003-09-03 | — | — | EP | disclosed |
| US-20030149089-A1 | Antibacterial compounds | SMITHKLINE BEECHAM CORPORATION | 2003-08-07 | — | — | US | disclosed |
| US-6559172-B1 | Treatment of bacterial infections, particularly through the inhibition of FAB I. and antiobiotics | SMITHKLINE BEECHAM CORPORATION | 2003-05-06 | — | — | US | disclosed |
| US-20030083398-A1 | Dental composition kit | KURARAY CO. LTD. (JP) | 2003-05-01 | — | — | US | disclosed |
| CN-1104413-C | Phenylalkylcarboxylic acid derivatives | SANKYO CO (JP) | 2003-04-02 | — | — | CN | disclosed |
| US-20030055123-A1 | Dental cement composition | KURARAY CO. LTD, (JP) | 2003-03-20 | — | — | US | disclosed |
| CN-1101380-C | 4-mercaptopyrrolidine derivatives as farnesyl transferase inhibitors | ZENECA LTD (GB) | 2003-02-12 | — | — | CN | disclosed |
| CN-1394567-A | Composition reagent box for dentistry | KURARAY CO (JP) | 2003-02-05 | — | — | CN | disclosed |
| CN-1394566-A | Tooth cement agent composition | KURARAY CO (JP) | 2003-02-05 | — | — | CN | disclosed |
| CN-1391484-A | Methods for enhancing chemotherapeutic efficacy and treating solid tumors | HEW CORP (US) | 2003-01-15 | — | — | CN | disclosed |
| EP-1269967-A1 | Dental composition kit | KURARAY CO., LTD. (JP) | 2003-01-02 | — | — | EP | disclosed |
| EP-1269968-A1 | Dental cement composition | KURARAY CO., LTD. (JP) | 2003-01-02 | — | — | EP | disclosed |
| EP-1261327-A2 | ADENOSINE RECEPTOR MODULATORS | F.HOFFMANN-LA ROCHE AG (CH) | 2002-12-04 | — | — | EP | disclosed |
| CN-1377647-A | 4-mercaptopyrrolidinyl derivative as fernesyl transferase inhibitor | ZENECA LTD (GB) | 2002-11-06 | — | — | CN | disclosed |
| WO-2002085820-A2 | CHIRAL ORGANIC COMPOUNDS AND METAL COORDINATION COMPLEXES THEREOF | INDIANA UNIVERSITY (US) | 2002-10-31 | — | — | WO | disclosed |
| EP-1194144-A4 | ANTIBACTERIAL COMPOUNDS | SMITHKLINE BEECHAM CORP (US) | 2002-08-07 | — | — | EP | disclosed |
| CN-1353713-A | Purine inhibitors of cyclin dependent kinase 2 and IK B-alpha | CV THERAPEUTICS INC (US) | 2002-06-12 | — | — | CN | disclosed |
| EP-0923551-B1 | 4-AMINOETHOXY INDOLONE DERIVATIVES | AMERICAN HOME PROD (US) | 2002-06-05 | — | — | EP | disclosed |
| EP-1194144-A1 | ANTIBACTERIAL COMPOUNDS | SMITHKLINE BEECHAM CORPORATION (US) | 2002-04-10 | — | — | EP | disclosed |
| CN-1079391-C | Preparation of N-alkyl naphthylamines | CHINA PETRO CHEM GROUP CORP (CN) | 2002-02-20 | — | — | CN | disclosed |
| EP-1177175-A2 | HETEROSUBSTITUTED PYRIDINE DERIVATIVES AS PDE 4 INHIBITORS | MERCK FROSST CANADA INC. (CA) | 2002-02-06 | — | — | EP | disclosed |
| WO-2001062233-A2 | ADENOSINE RECEPTOR MODULATORS | F. HOFFMANN LA ROCHE AG (CH) | 2001-08-30 | — | — | WO | disclosed |
| CN-1065532-C | Thiazolidine and oxazolidine derivatives, their preparation and their medical use | SANKYO CO (JP) | 2001-05-09 | — | — | CN | disclosed |
| US-6200993-B1 | ASTHMA; ANTIINFLAMMATORY AGENTS | MERCK FROSST CANADA & CO. (CA) | 2001-03-13 | — | — | US | disclosed |
| CN-1280570-A | Substituted fused heterocyclic compounds | SANKYO CO (JP) | 2001-01-17 | — | — | CN | disclosed |
| CN-1279680-A | Imidazole derivatives having farnesyl transferase inhibitory activity and process for producing the same | LG CHEMICAL LTD (KR) | 2001-01-10 | — | — | CN | disclosed |
| WO-2000071120-A1 | ANTIBACTERIAL COMPOUNDS | SMITHKLINE BEECHAM CORPORATION (US) | 2000-11-30 | — | — | WO | disclosed |
| WO-2000068198-A2 | HETEROSUBSTITUTED PYRIDINE DERIVATIVES AS PDE 4 INHIBITORS | MERCK FROSST CANADA & CO. (CA) | 2000-11-16 | — | — | WO | disclosed |
| US-6133258-A | PYRIDOTHIAZINE DERIVATIVE; FOR TREATMENT OF AMYOTROPHIC LATERAL SCLEROSIS, MULTIPLE SCLEROSIS, PAIN, GLAUCOMA | YAMANOUCHI PHARMACEUTICAL CO., LTD. (JP) | 2000-10-17 | — | — | US | disclosed |
| US-6114310-A | THERAPY FOR MICROBIAL INFECTIONS | MICROCIDE PHARMACEUTICALS, INC. (US) | 2000-09-05 | — | — | US | disclosed |
| CN-1234024-A | 4-aminoethoxy indolone derivatives | AMERICAN HOME PROD (US) | 1999-11-03 | — | — | CN | disclosed |
| CN-1231611-A | Puring inhibitors of cylin dependent kinase 2 and I'kappa'beta-'alpha' | CV THERAPEUTIC INC (US) | 1999-10-13 | — | — | CN | disclosed |
| EP-0923551-A1 | 4-AMINOETHOXY INDOLONE DERIVATIVES | AMERICAN HOME PRODUCTS CORPORATION (US) | 1999-06-23 | — | — | EP | disclosed |
| EP-0918757-A1 | 8-HYDROCARBYL SUBSTITUTED BENZODIZOCINE DERIVATIVES, THEIR PREPARATION AND THEIR USE AS PROTEIN KINASE C (=PKC) MODULATORS | GEORGETOWN UNIVERSITY (US) | 1999-06-02 | — | — | EP | disclosed |
| CN-1214338-A | Preparation of N-alkyl naphthylamines | CHINA PETROCHEMICAL CORP (CN) | 1999-04-21 | — | — | CN | disclosed |
| CN-1202109-A | Kainic acid neuronotoxicity inhibitors and pyridothioazine derivatives | YAMANOUCHI PHARMA CO LTD (JP) | 1998-12-16 | — | — | CN | disclosed |
| EP-0878196-A1 | KAINIC ACID NEURONOTOXICITY INHIBITORS AND PYRIDOTHIAZINE DERIVATIVES | YAMANOUCHI PHARMACEUTICAL CO. LTD. (JP) | 1998-11-18 | — | — | EP | disclosed |
| CN-1197453-A | 4-mercaptopyrrolidine derivatives as farnesyl transferase inhibitors | ZENECA LTD (GB) | 1998-10-28 | — | — | CN | disclosed |
| US-5817690-A | ANTIDOPAMINE AGENTS | AMERICAN HOME PRODUCTS CORPORATION (US) | 1998-10-06 | — | — | US | disclosed |
| WO-1998008819-A1 | 4-AMINOETHOXY INDOLONE DERIVATIVES | AMERICAN HOME PRODUCTS CORPORATION (US) | 1998-03-05 | — | — | WO | disclosed |
| WO-1997043268-A1 | 8-HYDROCARBYL SUBSTITUTED BENZODIZOCINE DERIVATIVES, THEIR PREPARATION AND THEIR USE AS PROTEIN KINASE C (=PKC) MODULATORS | GEORGETOWN UNIVERSITY (US) | 1997-11-20 | — | — | WO | disclosed |
| US-5618814-A | Trisubstituted pyrimido [5,4-d] pyrimidines for modulating multi-drug resistance and pharmaceutical compositions containing these compounds | DR. KARL THOMAE GMBH (DE) | 1997-04-08 | — | — | US | disclosed |
| EP-0540673-B1 | ACETYLENE DERIVATIVES HAVING LIPOXYGENASE INHIBITORY ACTIVITY | ABBOTT LAB (US) | 1996-10-16 | — | — | EP | disclosed |
| CN-1132750-A | Thiazolidine and oxazolidine derivatives, their preparation and their medical use | SANKYO CO (JP) | 1996-10-09 | — | — | CN | disclosed |
| US-5559144-A | LIPOXYGENASE INHIBITORS, INHIBITORS OF BIOSYNTHESIS OF LEUKOTRIENES | ABBOTT LABORATORIES (US) | 1996-09-24 | — | — | US | disclosed |
| US-5476873-A | Inhibit biosynthesis of leukotrienes | ABBOTT LABORATORIES (US) | 1995-12-19 | — | — | US | disclosed |
| WO-1994014762-A1 | OXIME ETHER DERIVATIVES HAVING LIPOXYGENASE INHIBITORY ACTIVITY | ABBOTT LABORATORIES (US) | 1994-07-07 | — | — | WO | disclosed |
| US-5326883-A | Oxime ether derivatives having lipoxygenase inhibitory activity | ABBOTT LABORATORIES (US) | 1994-07-05 | — | — | US | disclosed |
| US-5288743-A | Lipoxygenase inhibitors | ABBOTT LABORATORIES (US) | 1994-02-22 | — | — | US | disclosed |
| US-5250565-A | Must incorporate a metabolically cleavable leaving group; pro-drugs; administering to mammals | ABBOTT LABORATORIES (US) | 1993-10-05 | — | — | US | disclosed |
| US-5204453-A | Process for the preparation of 1:2 metal complex azo compounds by carrying out diazotization and coupling in the presence of a metal donor | CIBA-GEIGY CORPORATION (US) | 1993-04-20 | — | — | US | disclosed |
| EP-0278910-B1 | HEAVY METAL COMPLEX DYESTUFFS, THEIR PREPARATION AND THEIR USE | CIBA-GEIGY AG (CH) | 1992-01-22 | — | — | EP | disclosed |
| EP-0241414-B1 | PROCESS FOR THE PREPARATION OF 1:2 METAL COMPLEX AZO DYES | CIBA-GEIGY AG (CH) | 1991-05-08 | — | — | EP | disclosed |
| US-5001227-A | Fibre-reactive 1:1 chromium complex azo or azomethine dyes having a bidentate chelating group and a monofunctional neutral ligand | CIBA-GEIGY CORPORATION (US) | 1991-03-19 | — | — | US | disclosed |
| US-4990598-A | Colorfastness | CIBA-GEIGY CORPORATION, A CORP. OF NEW YORK | 1991-02-05 | — | — | US | disclosed |
| US-4960870-A | DYEING WOOL, POLYAMIDES; FIBER REACTIVE DYES | CIBA-GEIGY CORPORATION (US) | 1990-10-02 | — | — | US | disclosed |
| EP-0142104-B1 | FIBRE-REACTIVE CHROMIUM COMPLEXES, THEIR PREPARATION AND THEIR USE | CIBA-GEIGY AG (CH) | 1990-01-03 | — | — | EP | disclosed |
| US-4889946-A | Phenoxybenzoic acid compounds and herbicidal and plant growth regulant compositions | BAYER AKTIENGESELLSCHAFT (DE) | 1989-12-26 | — | — | US | disclosed |
| US-4874391-A | USING WATER SOLUBLE COPPER COMPLEX AZO DYE, LIGHT STABILIZER AND ANTIOXIDANT | CIBA-GEIGY CORPORATION (US) | 1989-10-17 | — | — | US | disclosed |
| EP-0144776-B1 | FIBRE-REACTIVE CHROMIUM COMPLEXES, THEIR PREPARATION AND THEIR USE | CIBA-GEIGY AG (CH) | 1989-10-11 | — | — | EP | disclosed |
| EP-0141416-B1 | FIBRE-REACTIVE CHROMIUM COMPLEXES, THEIR PREPARATION AND THEIR USE | CIBA-GEIGY AG (CH) | 1989-08-16 | — | — | EP | disclosed |
| US-4833243-A | BENZOOXAZOLES OR BENZOTHIAZOLES | BAYER AKTIENGESELLSCHAFT (DE) | 1989-05-23 | — | — | US | disclosed |
| US-4813972-A | USING LEVELING DYES, COLORFASTNESS | CIBA-GEIGY CORPORATION (US) | 1989-03-21 | — | — | US | disclosed |
| EP-0159962-B1 | FIBRE-REACTIVE CHROMIUM OR COBALT COMPLEXES, THEIR PREPARATION AND THEIR USE | CIBA-GEIGY AG (CH) | 1989-02-08 | — | — | EP | disclosed |
| EP-0185611-B1 | PROCESS FOR THE PHOTOCHEMICAL STABILISATION OF SYNTHETIC FIBROUS MATERIALS CONTAINING POLYAMIDE FIBRES | CIBA-GEIGY AG (CH) | 1988-09-21 | — | — | EP | disclosed |
| EP-0278910-A2 | Heavy metal complex dyestuffs, their preparation and their use | CIBA-GEIGY AG (CH) | 1988-08-17 | — | — | EP | disclosed |
| US-4756741-A | Azolyloxy-carboxylic acid amide compounds and herbicidal compositions | BAYER AKTIENGESELLSCHAFT (DE) | 1988-07-12 | — | — | US | disclosed |
| EP-0255481-A1 | Process for the photochemical stabilisation of a fibrous polyamide material and its mixtures with other fibres | CIBA-GEIGY AG (CH) | 1988-02-03 | — | — | EP | disclosed |
| US-4723001-A | Fibre-reactive chromium complexes and their preparation and use | CIBA-GEIGY CORPORATION (US) | 1988-02-02 | — | — | US | disclosed |
| US-4719053-A | FOR DYES | HOECHST AKTIENGESELLSCHAFT (DE) | 1988-01-12 | — | — | US | disclosed |
| US-4704133-A | FIBER-REACTIVE | CIBA-GEIGY CORPORATION (US) | 1987-11-03 | — | — | US | disclosed |
| EP-0241414-A2 | Process for the preparation of 1:2 metal complex azo dyes | CIBA-GEIGY AG (CH) | 1987-10-14 | — | — | EP | disclosed |
| US-4680385-A | Metal dye complexes containing an azo or azomethine dye and a colorless ligand with the C═N--N═C group | CIBA-GEIGY CORPORATION (US) | 1987-07-14 | — | — | US | disclosed |
| US-4678851-A | FIBER-RACTIVE | CIBA-GEIGY CORPORATION (US) | 1987-07-07 | — | — | US | disclosed |
| US-4645525-A | Azolyoxy-carboxylic acid amide compounds and herbicidal compositions | BAYER AKTIENGESELLSCHAFT (DE) | 1987-02-24 | — | — | US | disclosed |
| US-4585471-A | PREEMERGENCE | BAYER AKTIENGESELLSCHAFT (DE) | 1986-04-29 | — | — | US | disclosed |
| EP-0159962-A2 | Fibre-reactive chromium or cobalt complexes, their preparation and their use | CIBA-GEIGY AG (CH) | 1985-10-30 | — | — | EP | disclosed |
| US-4549899-A | Hericidally active novel substituted 3-trihalogenomethyl-1,2,4-thiadiazol-5-yl-oxyacetamides | BAYER AKTIENGESELLSCHAFT (DE) | 1985-10-29 | — | — | US | disclosed |
| US-4540430-A | Herbicidally active novel substituted 3-trichloromethyl-1,2,4-thiadiazol-5-yl-oxyacetamides | BAYER AKTIENGESELLSCHAFT (DE) | 1985-09-10 | — | — | US | disclosed |
| EP-0045488-B1 | WATER-SOLUBLE FIBRE-REACTIVE COMPOUNDS AND THEIR USE IN FINISHING TEXTILES, AS WELL AS THE BETA-CHLOROETHYL-SULFONYL-METHYL-BENZOIC-ACID HALOGENIDES, AND THEIR USE AS A FIBRE-REACTIVE ANCHOR | HOECHST AKTIENGESELLSCHAFT (DE) | 1985-06-19 | — | — | EP | disclosed |
| EP-0144776-A2 | Fibre-reactive chromium complexes, their preparation and their use | CIBA-GEIGY AG (CH) | 1985-06-19 | — | — | EP | disclosed |
| EP-0142104-A2 | Fibre-reactive chromium complexes, their preparation and their use | CIBA-GEIGY AG (CH) | 1985-05-22 | — | — | EP | disclosed |
| EP-0141416-A2 | Fibre-reactive chromium complexes, their preparation and their use | CIBA-GEIGY AG (CH) | 1985-05-15 | — | — | EP | disclosed |
| US-4509971-A | Benzothiazole substituted carboxylic acid amide compounds and herbicidal methods compositions thereof | BAYER AKTIENGESELLSCHAFT (DE) | 1985-04-09 | — | — | US | disclosed |
| US-4473498-A | Water-soluble, fiber-reactive organic dyestuffs containing a β-chloro-ethylsulfonyl-methyl-benzoic acid amide group | HOECHST AKTIENGESELLSCHAFT (DE) | 1984-09-25 | — | — | US | disclosed |
| US-4455428-A | HERBICIDES | BAYER AKTIENGESELLSCHAFT (DE) | 1984-06-19 | — | — | US | disclosed |
| US-4399285-A | HERBICIDES | BAYER AKTIENGESELLSCHAFT (DE) | 1983-08-16 | — | — | US | disclosed |
| EP-0012969-B1 | WATER-SOLUBLE FIBRE-REACTIVE COMPOUNDS AND THEIR USE IN FIBRE FINISHING,ESPECIALLY AS DYESTUFFS,AND DIHALOGENO-PYRIDAZONYL-CARBOXYLIC AND SULFONIC ACID HALIDES AND THEIR USE AS FIBRE-REACTIVE ANCHORS,AS WELL AS PROCESS FOR THE PREPARATION OF THESE COMPOUND | HOECHST AKTIENGESELLSCHAFT (DE) | 1983-06-08 | — | — | EP | disclosed |
| US-4334073-A | BASIC CATALYSTS, DEACETYLATION, ESTERIFICATION | BAYER AKTIENGESELLSCHAFT (DE) | 1982-06-08 | — | — | US | disclosed |
| EP-0045488-A2 | Water-soluble fibre-reactive compounds and their use in finishing textiles, as well as the beta-chloroethyl-sulfonyl-methyl-benzoic-acid halogenides, and their use as a fibre-reactive anchor | HOECHST AKTIENGESELLSCHAFT (DE) | 1982-02-10 | — | — | EP | disclosed |
| EP-0030676-A1 | Derivatives of phenoxybenzoic acid, process for their preparation and their use as herbicides and as plant growth regulators | BAYER AG (DE) | 1981-06-24 | — | — | EP | disclosed |
| EP-0030287-A1 | 1-Aminocyclopropanecarboxylic acid derivatives, methods for their production, their use as plant-growth regulators and compositions containing such derivatives | BAYER AG (DE) | 1981-06-17 | — | — | EP | disclosed |
| EP-0012969-A2 | Water-soluble fibre-reactive compounds and their use in fibre finishing,especially as dyestuffs,and dihalogeno-pyridazonyl-carboxylic and sulfonic acid halides and their use as fibre-reactive anchors,as well as process for the preparation of these compound | HOECHST AKTIENGESELLSCHAFT (DE) | 1980-07-09 | — | — | EP | disclosed |
| US-4116952-A | POLYAMIDES | CIBA-GEIGY CORPORATION (US) | 1978-09-26 | — | — | US | disclosed |
| US-RE29585-E | DYEING WOOL | CIBA-GEIGY CORPORATION (US) | 1978-03-21 | — | — | US | disclosed |
| US-4067903-A | Manufacture of arylamines | BASF AKTIENGESELLSCHAFT (DT) | 1978-01-10 | — | — | US | disclosed |
| US-4065492-A | Process for preparing aminonaphthalene derivatives in a titanium or titanium alloy reactor | BAYER AKTIENGESELLSCHAFT (DT) | 1977-12-27 | — | — | US | disclosed |
| US-4033942-A | Chromium complex dye, including azo and azo methine dye compounds | CIBA-GEIGY AG (CH) | 1977-07-05 | — | — | US | disclosed |
| US-4002606-A | FIBER-REACTIVE DYES | HOECHST AKTIENGESELLSCHAFT (DT) | 1977-01-11 | — | — | US | disclosed |
| US-3978037-A | POLYAMIDES | CIBA-GEIGY CORPORATION (US) | 1976-08-31 | — | — | US | disclosed |
| US-3971738-A | Heavy metal complexes of azo compounds containing a halogeno-2,3-dihydroxy pyridine coupling component | CIBA-GEIGY AG (CH) | 1976-07-27 | — | — | US | disclosed |
| US-3933785-A | Azo compounds | CIBA-GEIGY AG (CH) | 1976-01-20 | — | — | US | disclosed |
| US-3933785-A | Azo compounds | CIBA-GEIGY AG (CH) | 1976-01-20 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (50 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160194284-A1 | ALLOSTERIC MODULATORS OF THE CANNABINOID 1 RECEPTOR | CNR1, CNR2, GPR119 | ALDH1A1 2771/4885CYP1A2 1120/4885CYP3A4 1339/4885 |
| US-20130217685-A1 | COMPOUNDS FOR MODULATING RNA BINDING PROTEINS AND USES THEREFOR | TIA1, ZFP3, RBM3 | ALDH1A1 3135/4885CYP1A2 4801/4885CYP3A4 4278/4885 |
| US-20120202821-A1 | CONFORMATIONALLY CONSTRAINED, FULLY SYNTHETIC MACROCYCLIC COMPOUNDS | HTR2B, MC1R, HTR1A | ALDH1A1 4268/4885CYP1A2 882/4885CYP3A4 1869/4885 |
| US-20070294842-A1 | Reactive Dyes, a Process for Their Preparation and Their Use | CBR3, ARSA, CBR1 | ALDH1A1 397/4885CYP1A2 1208/4885CYP3A4 625/4885 |
| US-20230122957-A1 | PSMA LIGANDS FOR IMAGING AND ENDORADIOTHERAPY | KLK3, FOLH1, EEA1 | ALDH1A1 1331/4885CYP1A2 4483/4885CYP3A4 4103/4885 |
| US-20100125140-A1 | AMINOTETRALIN-DERIVED UREA MODULATORS OF VANILLOID VR1 RECEPTOR | UTS2R, TRPV1, GPR17 | ALDH1A1 1211/4885CYP1A2 1934/4885CYP3A4 1496/4885 |
| US-20230133581-A1 | Novel 3,5-Diaminobenzoic Acid Compound, and PIN1 Inhibitor and Therapeutic Agent for Inflammatory Diseases Using Same | PIN1, DUSP15, FKBP1A | ALDH1A1 2183/4885CYP1A2 1141/4885CYP3A4 1308/4885 |
| US-20240400568-A1 | DIACYLGLYCEROL KINASE MODULATING COMPOUNDS | DGKG, DGKB, DGKK | ALDH1A1 4095/4885CYP1A2 4595/4885CYP3A4 4334/4885 |
| US-20230203048-A1 | SPIROPYRROLIDINE DERIVED ANTIVIRAL AGENTS | ACE, ACE2, PKD1 | ALDH1A1 319/4885CYP1A2 1377/4885CYP3A4 221/4885 |
| US-20170174639-A1 | EIS INHIBITORS | ABCC1, ATP5ME, ABCG2 | ALDH1A1 819/4885CYP1A2 2393/4885CYP3A4 2869/4885 |
| US-20080097102-A1 | AMINOTETRALIN-DERIVED UREA MODULATORS OF VANILLOID VR1 RECEPTOR | UTS2R, TRPV1, GPR17 | ALDH1A1 1211/4885CYP1A2 1934/4885CYP3A4 1496/4885 |
| US-20070282101-A1 | Indazole compounds | CYP3A43, CYP3A7, UGT1A1 | ALDH1A1 89/4885CYP1A2 15/4885CYP3A4 5/4885 |
| US-11370740-B2 | Method for producing ester group-containing compound | COASY, TAF5, TAF9 | ALDH1A1 1667/4885CYP1A2 1185/4885CYP3A4 673/4885 |
| US-20260112544-A1 | ELECTROLYTIC CAPACITOR | ASIC1, SLC9A2, SLC25A13 | ALDH1A1 508/4885CYP1A2 1225/4885CYP3A4 1967/4885 |
| US-20110195999-A1 | NOVEL ANTIFUNGAL AGENT CONTAINING HETEROCYCLIC COMPOUND | ERG28, CYP51A1, XPO1 | ALDH1A1 1677/4885CYP1A2 147/4885CYP3A4 61/4885 |
| US-20120071478-A1 | SUBSTITUTED BENZOTRIAZINES AND QUINOXALINES AS INHIBITORS OF P7OS6 KINASE | CDK1, CDK2, CDK6 | ALDH1A1 4137/4885CYP1A2 1508/4885CYP3A4 2000/4885 |
| US-20220324866-A1 | DIACYLGLYCEROL KINASE MODULATING COMPOUNDS | DGKG, DGKB, DGKK | ALDH1A1 4095/4885CYP1A2 4595/4885CYP3A4 4334/4885 |
| US-20230250048-A1 | NITROGEN-CONTAINING COMPOUND, ELECTRONIC ELEMENT AND ELECTRONIC DEVICE | NOS1, NOM1, NCF1 | ALDH1A1 1717/4885CYP1A2 1640/4885CYP3A4 1315/4885 |
| US-20090227799-A1 | Novel Antimalarial Agent Containing Heterocyclic Compound | XPO1, THPO, G6PD | ALDH1A1 1926/4885CYP1A2 1886/4885CYP3A4 1535/4885 |
| US-20230301182-A1 | ORGANIC COMPOUND, AND ELECTRONIC ELEMENT AND ELECTRONIC DEVICE USING SAME | OR10J3, ESR1, EPCAM | ALDH1A1 496/4885CYP1A2 428/4885CYP3A4 309/4885 |
| US-20230322656-A1 | ORGANIC COMPOUND, AND ELECTRONIC COMPONENT AND ELECTRONIC DEVICE HAVING SAME | PIEZO1, OR10J3, ODC1 | ALDH1A1 237/4885CYP1A2 213/4885CYP3A4 133/4885 |
| US-20160368881-A1 | THERAPEUTIC COMPOUNDS | HAVCR2, SARS1, RPL35 | ALDH1A1 429/4885CYP1A2 782/4885CYP3A4 358/4885 |
| US-20090275578-A1 | Isoindolone compounds and their use as metabotropic glutamate receptor potentiators | GRM1, GRIN1, GRM3 | ALDH1A1 1582/4885CYP1A2 1256/4885CYP3A4 1095/4885 |
| US-10227364-B2 | Silane and silicic acid (hetero)polycondensate having aromatic compounds linked via coupling groups which are suitable as or for matrix systems having high translucency and good mechanical properties | NR4A1, SMC4, NR4A2 | ALDH1A1 4377/4885CYP1A2 4394/4885CYP3A4 2510/4885 |
| US-20050187291-A1 | use of 2-(urea or thiourea)tetralins as analgesic or to treat pulmonary dysfunction | TMEM109, UTS2R, GPR17 | ALDH1A1 1133/4885CYP1A2 1823/4885CYP3A4 2581/4885 |
| US-20080096925-A1 | Novel Substituted 4-Phenyl-4[H-Imidazol-2-YL]-Piperidine Derivatived And Their Use As Selective Non-Peptide Delta Opioid Agonists | OPRD1, OPRK1, OPRL1 | ALDH1A1 1647/4885CYP1A2 1627/4885CYP3A4 1049/4885 |
| US-11767291-B2 | Preparation of secondary amines with electrophilic N-linchpin reagents | PNMT, NCL, NPM1 | ALDH1A1 1805/4885CYP1A2 2396/4885CYP3A4 3968/4885 |
| US-20200383987-A1 | Novel Amide Compound, and Pin1 Inhibitor, Therapeutic Agent for Inflammatory Diseases and Therapeutic Agent for Cancer That Use the Same | PIN1, FKBP1A, FKBP5 | ALDH1A1 3518/4885CYP1A2 2435/4885CYP3A4 3220/4885 |
| US-12054490-B2 | Diacylglycerol kinase modulating compounds | DGKG, DGKB, DGKK | ALDH1A1 4095/4885CYP1A2 4595/4885CYP3A4 4334/4885 |
| US-20040143118-A1 | Chiral organic compounds and metal coordination complexes thereof | ORC3, SOD1, SLC39A3 | ALDH1A1 3442/4885CYP1A2 1967/4885CYP3A4 1059/4885 |
| US-20130029878-A1 | Method for Assaying Histone Methylation Enzyme Activity | EHMT1, DOT1L, EHMT2 | ALDH1A1 1742/4885CYP1A2 3922/4885CYP3A4 3405/4885 |
| US-20070105943-A1 | Novel antifungal agent containing heterocyclic compound | ERG28, DPM1, CYP51A1 | ALDH1A1 1459/4885CYP1A2 187/4885CYP3A4 104/4885 |
| US-20200297876-A1 | PSMA ligands for imaging and endoradiotherapy | KLK3, FOLH1, EEA1 | ALDH1A1 1331/4885CYP1A2 4483/4885CYP3A4 4103/4885 |
| US-12531188-B2 | Electrolytic capacitor | ASIC1, SLC1A2, HCN2 | ALDH1A1 1325/4885CYP1A2 2181/4885CYP3A4 2762/4885 |
| US-11845723-B2 | Diacylglycerol kinase modulating compounds | DGKG, DGKB, DGKK | ALDH1A1 4095/4885CYP1A2 4595/4885CYP3A4 4334/4885 |
| US-20230200209-A1 | ORGANOMETALLIC COMPOUND AND ORGANIC LIGHT-EMITTING DIODE INCLUDING THE SAME | CRY1, ZFX, PPOX | ALDH1A1 315/4885CYP1A2 523/4885CYP3A4 237/4885 |
| US-20040204455-A1 | Piperidine derivative rennin inhibitors | REN, ACE, HPN | ALDH1A1 921/4885CYP1A2 2821/4885CYP3A4 2949/4885 |
| US-20030149089-A1 | Antibacterial compounds | MRPL21, MRPS28, SPOUT1 | ALDH1A1 388/4885CYP1A2 742/4885CYP3A4 698/4885 |
| US-11130780-B2 | Inhibitors of growth factor activation enzymes | HDGF, MMP7, HGF | ALDH1A1 2862/4885CYP1A2 977/4885CYP3A4 1459/4885 |
| US-20230303537-A1 | NITROGEN-CONTAINING COMPOUND, AND ELECTRONIC ELEMENT AND ELECTRONIC DEVICE THEREOF | NPM1, NFE2L2, MNS1 | ALDH1A1 2635/4885CYP1A2 1184/4885CYP3A4 2158/4885 |
| US-20160185804-A1 | SILANE AND SILICIC ACID (HETERO)POLYCONDENSATE HAVING AROMATIC COMPOUNDS LINKED VIA COUPLING GROUPS WHICH ARE SUITABLE AS OR FOR MATRIX SYSTEMS HAVING HIGH TRANSLUCENCY AND GOOD MECHANICAL PROPERTIES | NR4A1, SMC4, NR4A2 | ALDH1A1 4377/4885CYP1A2 4394/4885CYP3A4 2510/4885 |
| US-20150239894-A1 | Amino Compounds for Treatment of Complement Mediated Disorders | CFD, TFPI, C9 | ALDH1A1 3450/4885CYP1A2 4580/4885CYP3A4 4463/4885 |
| US-10202353-B2 | Therapeutic compounds | RPL35, SARS1, HAVCR2 | ALDH1A1 424/4885CYP1A2 903/4885CYP3A4 488/4885 |
| US-20240182476-A1 | DIACYLGLYCEROL KINASE MODULATING COMPOUNDS | DGKG, DGKB, DGKK | ALDH1A1 4095/4885CYP1A2 4595/4885CYP3A4 4334/4885 |
| US-20250361236-A9 | DIACYLGLYCEROL KINASE MODULATING COMPOUNDS | DGKG, DGKB, DGKK | ALDH1A1 4095/4885CYP1A2 4595/4885CYP3A4 4334/4885 |
| US-20230355609-A1 | Spirolactone Compounds | ACACA, AKR1C2, AKR1A1 | ALDH1A1 40/4885CYP1A2 204/4885CYP3A4 1349/4885 |
| US-20070149495-A1 | HISTONE DEACETYLASE INHIBITORS | HDAC1, HDAC3, HDAC11 | ALDH1A1 2744/4885CYP1A2 4543/4885CYP3A4 4453/4885 |
| US-20080027060-A1 | DIPEPTIDE NITRILES | CTSL, CTSS, CTSB | ALDH1A1 4249/4885CYP1A2 3454/4885CYP3A4 895/4885 |
| US-20150360214-A1 | REACTION CATALYST FOR CROSS-COUPLING AND METHOD FOR MANUFACTURING AROMATIC COMPOUND | ALK, HRH4, HRH3 | ALDH1A1 2351/4885CYP1A2 516/4885CYP3A4 237/4885 |
| US-20240024266-A1 | Therapeutic Agent or Prophylactic Agent for COVID-19 | PIN1, ACE2, ACE | ALDH1A1 4006/4885CYP1A2 4049/4885CYP3A4 3976/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.